Loading... Please wait... Loading... Please wait...
ESTIMATED
05/07/2024
05/07/2024
(AS OF MARCH 31)
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.07 | -$0.07 | -$0.07 |
| Q2 2024 | 2 | $0.07 | $0.07 | $0.07 |
| Q3 2024 | 0 | $0.04 | $0.04 | $0.04 |
| Q4 2024 | 0 | $0.12 | $0.12 | $0.12 |
| Q1 2025 | 1 | $0.08 | $0.08 | $0.08 |
| Q2 2025 | 1 | $0.14 | $0.14 | $0.14 |
| Q3 2025 | 1 | $0.07 | $0.07 | $0.07 |
| Q4 2025 | 1 | $0.17 | $0.17 | $0.17 |
Bioventus Inc. last posted its earnings results on Tuesday, May 7th, 2024. The company reported $0.07 earnings per share for the quarter, topping analysts' consensus estimates of $-0.05 by $0.12. The company had revenue of 129.46 M for the quarter and had revenue of 512.35 M for the year. Bioventus Inc. has generated $-2 earnings per share over the last year ($-2.49 diluted earnings per share) and currently has a price-to-earnings ratio of -17.17. Bioventus Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/07/2024 | Q1 2024 | -$0.05 | -$0.07 | -0.02 | $118.37 M | $129.46 M | 03/12/2024 | Q4 2023 | $0.06 | -$0.10 | -0.16 | $135.42 M | 11/07/2023 | Q3 2023 | $0.06 | -$0.12 | -0.18 | $119.00 M | $120.79 M | 08/08/2023 | Q2 2023 | $0.03 | -$0.06 | -0.09 | $137.07 M | 05/16/2023 | Q1 2023 | -$0.11 | -$1.61 | -1.5 | $119.06 M | 03/31/2023 | Q4 2022 | $0.05 | -$0.72 | -0.77 | $125.83 M | 11/21/2022 | Q3 2022 | $0.13 | $0.05 | -0.08 | $137.07 M | 08/12/2022 | Q2 2022 | -$0.13 | $140.33 M | 05/11/2022 | Q1 2022 | -$0.24 | $117.29 M | 03/11/2022 | Q4 2021 | -$0.01 | $130.23 M | $130.41 M | 11/10/2021 | Q3 2021 | -$0.03 | $108.89 M | 08/11/2021 | Q2 2021 | -$0.10 | $109.82 M | 05/13/2021 | Q1 2021 | $0.60 | $81.78 M | 03/26/2021 | Q4 2020 | $0.07 | $98.08 M | $98.59 M | 09/30/2020 | Q3 2020 | $0.15 | $85.91 M | 06/30/2020 | Q2 2020 | -$0.10 | $58.02 M | 03/31/2020 | Q1 2020 | $0.20 | $78.65 M | 12/31/2019 | Q4 2019 | $0.10 | $97.55 M | 03/31/2016 | Q1 2016 | -$0.11 | $65.40 M | 03/31/2015 | Q1 2015 | -$0.38 | $53.36 M |
|---|
A. Bioventus Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates.
A. In the previous quarter, Bioventus Inc. (NASDAQ:BVS) reported $0.07 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.05 by $0.12.
A. The conference call for Bioventus Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for Bioventus Inc.'s latest earnings report can be read online.
A. Bioventus Inc. (NASDAQ:BVS) has a recorded annual revenue of $512.35 M.
A. Bioventus Inc. (NASDAQ:BVS) has a recorded net income of $512.35 M. Bioventus Inc. has generated $-2.49 earnings per share over the last four quarters.
A. Bioventus Inc. (NASDAQ:BVS) has a price-to-earnings ratio of -17.17 and price/earnings-to-growth ratio is -1.45.
